Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Foreign OTC Firms Fail US FDA Review Of Records For Diethylene Glycol Testing, Or Fail To Reply

09 Aug 2023

• By Malcolm Spicer

• Source: Shutterstock

Related Content

Revised US FDA Guidance Calls For Testing More Excipients For DEG And EG

11 May 2023

Updated USP Glycerin Standard Should Prevent Product Adulteration

16 Feb 2009

US FDA Warns NJ Firm On Drug And Supplement GMPs, Indian Firm On Diethylene Glycol Testing

11 Apr 2023

How The US FDA Is Checking For Adequate Controls Against DEG/EG Ingredient Substitution

18 May 2023

Preparing For The Return Of US FDA Inspections

15 Feb 2021

Additional Topics

International India Asia Pacific South Korea Europe Middle East and Africa Canada United States US States FDA OTC Drugs Warning Letters Coronavirus COVID-19 Compliance Consumer Cosmetics Distribution Drug Safety Enforcement Ingredients Manufacturing Policy Recalls Regulation Retail Safety Supply Chain

More from Regulation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.